Impact of statin-ezetimibe combination on coronary atheroma plaque in patients with and without chronic kidney disease — Sub-analysis of PRECISE-IVUS trial

Koichiro Fujisue,Suguru Nagamatsu,Hideki Shimomura,Takuro Yamashita,Koichi Nakao,Sunao Nakamura,Masaharu Ishihara,Kunihiko Matsui,Nobuyasu Yamamoto,Shunichi Koide,Toshiyuki Matsumura,Kazuteru Fujimoto,Ryusuke Tsunoda,Yasuhiro Morikami, Koshi Matsuyama,Shuichi Oshima,Kenji Sakamoto,Yasuhiro Izumiya,Koichi Kaikita,Seiji Hokimoto

International Journal of Cardiology（2018）

引用 4|浏览29

暂无评分

摘要

•Dual lipid-lowering therapy (DLLT) strongly reduced LDL cholesterol.•DLLT reduced coronary plaque in chronic kidney disease (CKD) patients.•DLLT inhibits cholesterol absorption in patients with CKD.•Inhibition of cholesterol absorption related to coronary plaque volume change

查看译文

关键词

Ezetimibe,Statins,Coronary plaque,Chronic kidney disease,Intravascular ultrasound

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要